Comparative efficacy and safety of ciprofol, propofol, and propofol and etomidate mixture, and ciprofol and etomidate mixture in patients undergoing painless gastroscopy: A randomized, double-blind controlled clinical trial
- PMID: 39252308
- DOI: 10.1097/MD.0000000000039585
Comparative efficacy and safety of ciprofol, propofol, and propofol and etomidate mixture, and ciprofol and etomidate mixture in patients undergoing painless gastroscopy: A randomized, double-blind controlled clinical trial
Abstract
Background: To compare the efficacy and safety of ciprofol, propofol, propofol and etomidate mixture or ciprofol and etomidate mixture in patients undergoing painless gastroscopic anesthesia, and to explore the optimal plan to relieve the patient's discomfort.
Methods: A total of 120 patients scheduled for painless gastroscopy were randomly assigned to 4 groups: propofol (Group P), ciprofol (Group C), propofol-etomidate mixture (Group P-E), and ciprofol-etomidate mixture (Group C-E). The success rate of gastroscopy examination, patient satisfaction, incidence of injection pain, hemodynamic parameters, induction time, procedure time, the consumption of drugs, awakening time, and incidence of adverse events were evaluated.
Results: All patients in the study successfully completed the gastroscopy. The satisfaction of patients in Group C-E was significantly higher than that in Group P (P < .05), but there was no statistical significance in the patient satisfaction among the other groups. Compared with Group P, the incidence of injection pain in Groups C and C-E significantly decreased (P < .05). There were no significant differences in the SBP, diastolic blood pressure, HR, and SpO2 among the 4 groups (P > .05). The awakening time of Group C was significantly longer than that of Groups P and P-E (P < .05), but there was no statistically significant difference in the awakening time of other groups.
Conclusion: Ciprofol demonstrated efficacy in inducing sedation or anesthesia during painless gastroscopy that was similar to propofol, while exhibiting a comparable safety profile. Moreover, the combination of propofol and etomidate, as well as the combination of ciprofol and etomidate, were both shown to be equally safe and effective for this clinical application. These findings suggest that ciprofol can be considered as a safe and effective alternative for painless gastroscopy, and the ciprofol-etomidate mixture may be a better choice.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
The efficacy and safety of ciprofol and propofol in patients undergoing colonoscopy: A double-blind, randomized, controlled trial.J Clin Anesth. 2024 Aug;95:111474. doi: 10.1016/j.jclinane.2024.111474. Epub 2024 Apr 11. J Clin Anesth. 2024. PMID: 38608531 Clinical Trial.
-
The efficacy and safety of ciprofol versus propofol in patients undergoing painless hysteroscopy: a randomized, double-blind, controlled trial.BMC Anesthesiol. 2024 Nov 12;24(1):411. doi: 10.1186/s12871-024-02787-0. BMC Anesthesiol. 2024. PMID: 39533194 Free PMC article. Clinical Trial.
-
Clinical observation of the combined use of propofol and etomidate in painless gastroscopy.Medicine (Baltimore). 2020 Nov 6;99(45):e23061. doi: 10.1097/MD.0000000000023061. Medicine (Baltimore). 2020. PMID: 33157963 Free PMC article.
-
Safety and efficacy of combined use of propofol and etomidate for sedation during gastroscopy: Systematic review and meta-analysis.Medicine (Baltimore). 2019 May;98(20):e15712. doi: 10.1097/MD.0000000000015712. Medicine (Baltimore). 2019. PMID: 31096522 Free PMC article.
-
Safety and efficacy of ciprofol versus propofol for gastrointestinal endoscopy: a meta-analysis.BMC Gastroenterol. 2025 Mar 3;25(1):130. doi: 10.1186/s12876-025-03734-0. BMC Gastroenterol. 2025. PMID: 40033212 Free PMC article.
Cited by
-
The novel ciprofol versus propofol during gastroenteroscopy in Chinese patients: a meta-analysis.Front Med (Lausanne). 2025 Jun 25;12:1598268. doi: 10.3389/fmed.2025.1598268. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40636379 Free PMC article.
References
-
- Men F, Wei L, Liu B, et al. Comparison of the safety of the application of painless gastroscopy and ordinary gastroscopy in chronic hypertension patients combined with early gastric cancer. Oncol Lett. 2018;15:3558–61.
-
- Zhan Y, Liang S, Yang Z, et al. Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial. BMC Gastroenterol. 2022;22:391.
-
- Wang JF, Xu HJ, He XM, Tang G, Wang LW, Cheng W. Predicting the best fit based on the synergistic interaction of remifentanil and propofol at the corrected dose in elderly patients undergoing painless gastroscopy. Am J Transl Res. 2022;14:8390–7.
-
- Zhou Y, Li YP. Safety and efficacy of etomidate in combination with oxycodone in painless gastroscopic procedures in the elderly: a prospective randomized controlled trial study. Medicine (Baltimore). 2023;102:e32612.
-
- Nazemroaya B, Shetabi H, Farsani DM, Ariya A. Comparison of sedation quality and pain with propofol-thiopental sodium versus propofol-etomidate in cataract surgery. Pak J Ophthalmol. 2024;40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources